_id
696959277a1974edb5dae86f
Ticker
AKTS
Name
Aktis Oncology, Inc. Common stock
Exchange
NASDAQ
Address
17 Drydock Avenue, Boston, MA, United States, 02210
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.aktisoncology.com
Description
Aktis Oncology, Inc. operates as a clinical-stage oncology company that engages in the development of targeted radiopharmaceutical therapies for cancer treatment. The company offers a miniprotein radioconjugate platform to discover and develop radiopharmaceutical therapies that deliver the tumor-killing properties of radioisotopes. It offers Nectin-4, a miniprotein radioconjugate for the treatment of locally advanced or metastatic urothelial cancer. Its products include AKY-1189 to deliver a radioisotope to Nectin-4 expressing tumors for the treatment of metastatic urothelial cancer, breast cancer, NSCLC, colorectal cancer and cervical cancer; and AKY-2519 to deliver radioisotope to B7-H3 CD276 expressing tumors targeting prostate, lung and other solid tumors. The company was formerly known as HotKnot Therapeutics, Inc. and changed its name to Aktis Oncology, Inc. in April 2020. Aktis Oncology, Inc. was incorporated in 2020 and is based in Boston, Massachusetts.
Last Close
19.76
Volume
33307
Current Price
19.85
Change
0.1
Last Updated
2026-01-20T15:07:15.000Z
Ipo Date
2026-01-09T00:00:00.000Z
Market Cap
1121350656
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.765
Sentiment Sources
12
Current Quarter
2024-12-31
Revenue
933000
Cost Of Revenue
-
Gross Profit
933000
Operating Expenses
16568000
Operating Income
-15635000
Interest Expense
-
Pretax Income
-12056000
Net Income
-12056000
Eps
-
Dividends Per Share
-
Shares Outstanding
50649450
Income Tax Expense
-
EBITDA
-15194000
Operating Margin
-1675.7770632368704
Total Other Income Expense Net
3579000
Cash
37159000
Short Term Investments
260009000
Receivables
-
Inventories
-
Total Current Assets
300853000
Property Plant Equipment
20871000
Total Assets
326181000
Payables
1918000
Short Term Debt
1296000
Long Term Debt
-
Total Liabilities
413984000
Equity
-87803000
Bs_currency_symbol
USD
Depreciation
441000
Change In Working Capital
-567000
Cash From Operations
-12799000
Capital Expenditures
2229000
Cash From Investing
-172882000
Cash From Financing
-1804000
Net Change In Cash
-187485000
Cf_currency_symbol
USD
PE
-
PB
-
ROE
13.730738129676661
ROA
-3.6961073759661045
FCF
-15028000
Fcf Percent
-16.107181136120044
Piotroski FScore
0
Health Score
35
Deep Value Investing Score
1
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
5.8
Garp Investing Score
1.5
Growth Investing Score
1
Momentum Investing Score
4
Net Net Investing Score
0.5
Quality Investing Score
1.5
Value Investing Score
2
Quarters > 0 > quarter
2024-12-31
Quarters > 0 > income Statement > revenue
933000
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
933000
Quarters > 0 > income Statement > operating Expenses
16568000
Quarters > 0 > income Statement > operating Income
-15635000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-12056000
Quarters > 0 > income Statement > net Income
-12056000
Quarters > 0 > income Statement > eps
-
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
-
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-15194000
Quarters > 0 > income Statement > operating Margin
-1675.7770632368704
Quarters > 0 > income Statement > total Other Income Expense Net
3579000
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
37159000
Quarters > 0 > balance Sheet > short Term Investments
260009000
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
300853000
Quarters > 0 > balance Sheet > property Plant Equipment
20871000
Quarters > 0 > balance Sheet > total Assets
326181000
Quarters > 0 > balance Sheet > payables
1918000
Quarters > 0 > balance Sheet > short Term Debt
1296000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
413984000
Quarters > 0 > balance Sheet > equity
-87803000
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-12056000
Quarters > 0 > cash Flow > depreciation
441000
Quarters > 0 > cash Flow > change In Working Capital
-567000
Quarters > 0 > cash Flow > cash From Operations
-12799000
Quarters > 0 > cash Flow > capital Expenditures
2229000
Quarters > 0 > cash Flow > cash From Investing
-172882000
Quarters > 0 > cash Flow > cash From Financing
-1804000
Quarters > 0 > cash Flow > net Change In Cash
-187485000
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-
Quarters > 0 > ratios > PB
-
Quarters > 0 > ratios > ROE
13.730738129676661
Quarters > 0 > ratios > ROA
-3.6961073759661045
Quarters > 0 > ratios > FCF
-15028000
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-16.107181136120044
Quarters > 0 > health Score
35
Quarters > 1 > quarter
2024-09-30
Quarters > 1 > income Statement > revenue
9027000
Quarters > 1 > income Statement > cost Of Revenue
4725000
Quarters > 1 > income Statement > gross Profit
4302000
Quarters > 1 > income Statement > operating Expenses
9638000
Quarters > 1 > income Statement > operating Income
-5336000
Quarters > 1 > income Statement > interest Expense
713000
Quarters > 1 > income Statement > pretax Income
-6419000
Quarters > 1 > income Statement > net Income
-6420000
Quarters > 1 > income Statement > eps
-0.04157322054652428
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
154426333
Quarters > 1 > income Statement > income Tax Expense
1000
Quarters > 1 > income Statement > EBITDA
-4021000
Quarters > 1 > income Statement > operating Margin
-59.11155422621026
Quarters > 1 > income Statement > total Other Income Expense Net
-1083000
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
224644000
Quarters > 1 > balance Sheet > short Term Investments
87770000
Quarters > 1 > balance Sheet > receivables
7029000
Quarters > 1 > balance Sheet > inventories
3168000
Quarters > 1 > balance Sheet > total Current Assets
315413000
Quarters > 1 > balance Sheet > property Plant Equipment
19387000
Quarters > 1 > balance Sheet > total Assets
337090000
Quarters > 1 > balance Sheet > payables
702000
Quarters > 1 > balance Sheet > short Term Debt
1486000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
413874000
Quarters > 1 > balance Sheet > equity
-76784000
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-6420000
Quarters > 1 > cash Flow > depreciation
1315000
Quarters > 1 > cash Flow > change In Working Capital
-5562000
Quarters > 1 > cash Flow > cash From Operations
-12201000
Quarters > 1 > cash Flow > capital Expenditures
133000
Quarters > 1 > cash Flow > cash From Investing
-185000
Quarters > 1 > cash Flow > cash From Financing
17222000
Quarters > 1 > cash Flow > net Change In Cash
-12386000
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
-0.04157322054652428
Quarters > 1 > ratios > PB
-39.921894015029174
Quarters > 1 > ratios > ROE
8.361116899354032
Quarters > 1 > ratios > ROA
-1.9045358806253525
Quarters > 1 > ratios > FCF
-12334000
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-1.366345408219785
Quarters > 1 > health Score
21
Quarters > 2 > quarter
2024-03-31
Quarters > 2 > income Statement > revenue
7510000
Quarters > 2 > income Statement > cost Of Revenue
7161000
Quarters > 2 > income Statement > gross Profit
349000
Quarters > 2 > income Statement > operating Expenses
15796000
Quarters > 2 > income Statement > operating Income
-22608000
Quarters > 2 > income Statement > interest Expense
745000
Quarters > 2 > income Statement > pretax Income
-23306000
Quarters > 2 > income Statement > net Income
-23308000
Quarters > 2 > income Statement > eps
-0.2553412110866069
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
91281779
Quarters > 2 > income Statement > income Tax Expense
2000
Quarters > 2 > income Statement > EBITDA
-19185000
Quarters > 2 > income Statement > operating Margin
-301.0386151797603
Quarters > 2 > income Statement > total Other Income Expense Net
-698000
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
15200000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
5569000
Quarters > 2 > balance Sheet > inventories
5104000
Quarters > 2 > balance Sheet > total Current Assets
28563000
Quarters > 2 > balance Sheet > property Plant Equipment
54237000
Quarters > 2 > balance Sheet > total Assets
102599000
Quarters > 2 > balance Sheet > payables
4796000
Quarters > 2 > balance Sheet > short Term Debt
2165000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
60694000
Quarters > 2 > balance Sheet > equity
41905000
Quarters > 2 > balance Sheet > currency_symbol
-
Quarters > 2 > cash Flow > net Income
-23308000
Quarters > 2 > cash Flow > depreciation
3376000
Quarters > 2 > cash Flow > change In Working Capital
2953000
Quarters > 2 > cash Flow > cash From Operations
-7791000
Quarters > 2 > cash Flow > capital Expenditures
291000
Quarters > 2 > cash Flow > cash From Investing
-291000
Quarters > 2 > cash Flow > cash From Financing
10407000
Quarters > 2 > cash Flow > net Change In Cash
2325000
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
-0.2553412110866069
Quarters > 2 > ratios > PB
43.239310658632625
Quarters > 2 > ratios > ROE
-55.62104760768405
Quarters > 2 > ratios > ROA
-22.717570346689538
Quarters > 2 > ratios > FCF
-8082000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-1.0761651131824235
Quarters > 2 > health Score
17
Quarters > 3 > quarter
2023-12-31
Quarters > 3 > income Statement > revenue
7017000
Quarters > 3 > income Statement > cost Of Revenue
6336000
Quarters > 3 > income Statement > gross Profit
681000
Quarters > 3 > income Statement > operating Expenses
15705000
Quarters > 3 > income Statement > operating Income
-15024000
Quarters > 3 > income Statement > interest Expense
679000
Quarters > 3 > income Statement > pretax Income
-15709000
Quarters > 3 > income Statement > net Income
-15711000
Quarters > 3 > income Statement > eps
-0.21496986310246788
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
73084663
Quarters > 3 > income Statement > income Tax Expense
2000
Quarters > 3 > income Statement > EBITDA
-11703000
Quarters > 3 > income Statement > operating Margin
-214.10859341598973
Quarters > 3 > income Statement > total Other Income Expense Net
-685000
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
12875000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
6061000
Quarters > 3 > balance Sheet > inventories
5476000
Quarters > 3 > balance Sheet > total Current Assets
26018000
Quarters > 3 > balance Sheet > property Plant Equipment
57356000
Quarters > 3 > balance Sheet > total Assets
111883000
Quarters > 3 > balance Sheet > payables
3187000
Quarters > 3 > balance Sheet > short Term Debt
956000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
58114000
Quarters > 3 > balance Sheet > equity
53769000
Quarters > 3 > balance Sheet > currency_symbol
-
Quarters > 3 > cash Flow > net Income
-15711000
Quarters > 3 > cash Flow > depreciation
3321000
Quarters > 3 > cash Flow > change In Working Capital
-952000
Quarters > 3 > cash Flow > cash From Operations
-11339000
Quarters > 3 > cash Flow > capital Expenditures
1625000
Quarters > 3 > cash Flow > cash From Investing
-1625000
Quarters > 3 > cash Flow > cash From Financing
52000
Quarters > 3 > cash Flow > net Change In Cash
-12912000
Quarters > 3 > cash Flow > currency_symbol
-
Quarters > 3 > ratios > PE
-0.21496986310246788
Quarters > 3 > ratios > PB
26.980798611653558
Quarters > 3 > ratios > ROE
-29.21943871003738
Quarters > 3 > ratios > ROA
-14.042347809765559
Quarters > 3 > ratios > FCF
-12964000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-1.847513182271626
Quarters > 3 > health Score
17
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
1487000
Annuals > 0 > income Statement > cost Of Revenue
28073000
Annuals > 0 > income Statement > gross Profit
1487000
Annuals > 0 > income Statement > operating Expenses
53537000
Annuals > 0 > income Statement > operating Income
-52050000
Annuals > 0 > income Statement > interest Expense
2658000
Annuals > 0 > income Statement > pretax Income
-43980000
Annuals > 0 > income Statement > net Income
-43980000
Annuals > 0 > income Statement > eps
-0.49368030834746723
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
89085992
Annuals > 0 > income Statement > income Tax Expense
6000
Annuals > 0 > income Statement > EBITDA
-50475000
Annuals > 0 > income Statement > operating Margin
-3500.336247478144
Annuals > 0 > income Statement > total Other Income Expense Net
8070000
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
37159000
Annuals > 0 > balance Sheet > short Term Investments
260009000
Annuals > 0 > balance Sheet > receivables
5295000
Annuals > 0 > balance Sheet > inventories
2223000
Annuals > 0 > balance Sheet > total Current Assets
300853000
Annuals > 0 > balance Sheet > property Plant Equipment
20871000
Annuals > 0 > balance Sheet > total Assets
326181000
Annuals > 0 > balance Sheet > payables
1918000
Annuals > 0 > balance Sheet > short Term Debt
1296000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
413984000
Annuals > 0 > balance Sheet > equity
-87803000
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-43980000
Annuals > 0 > cash Flow > depreciation
1575000
Annuals > 0 > cash Flow > change In Working Capital
58980000
Annuals > 0 > cash Flow > cash From Operations
14762000
Annuals > 0 > cash Flow > capital Expenditures
2862000
Annuals > 0 > cash Flow > cash From Investing
-190400000
Annuals > 0 > cash Flow > cash From Financing
183284000
Annuals > 0 > cash Flow > net Change In Cash
7646000
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-0.49368030834746723
Annuals > 0 > ratios > PB
-20.140051492545812
Annuals > 0 > ratios > ROE
50.08940469004476
Annuals > 0 > ratios > ROA
-13.483311412988494
Annuals > 0 > ratios > FCF
11900000
Annuals > 0 > ratios > Piotroski FScore
2
Annuals > 0 > ratios > fcf Percent
8.002689979825151
Annuals > 0 > health Score
50
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
27121000
Annuals > 1 > income Statement > cost Of Revenue
30237000
Annuals > 1 > income Statement > gross Profit
-3116000
Annuals > 1 > income Statement > operating Expenses
34794000
Annuals > 1 > income Statement > operating Income
-34794000
Annuals > 1 > income Statement > interest Expense
2322000
Annuals > 1 > income Statement > pretax Income
-28641000
Annuals > 1 > income Statement > net Income
-28641000
Annuals > 1 > income Statement > eps
-0.4501763996441027
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
63621727
Annuals > 1 > income Statement > income Tax Expense
-2448000
Annuals > 1 > income Statement > EBITDA
-33598000
Annuals > 1 > income Statement > operating Margin
-128.29172965598613
Annuals > 1 > income Statement > total Other Income Expense Net
6153000
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
29513000
Annuals > 1 > balance Sheet > short Term Investments
68349000
Annuals > 1 > balance Sheet > receivables
4753000
Annuals > 1 > balance Sheet > inventories
7548000
Annuals > 1 > balance Sheet > total Current Assets
100204000
Annuals > 1 > balance Sheet > property Plant Equipment
20924000
Annuals > 1 > balance Sheet > total Assets
122355000
Annuals > 1 > balance Sheet > payables
957000
Annuals > 1 > balance Sheet > short Term Debt
1528000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
168661000
Annuals > 1 > balance Sheet > equity
-46306000
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-28641000
Annuals > 1 > cash Flow > depreciation
1120000
Annuals > 1 > cash Flow > change In Working Capital
-15000
Annuals > 1 > cash Flow > cash From Operations
-30004000
Annuals > 1 > cash Flow > capital Expenditures
3764000
Annuals > 1 > cash Flow > cash From Investing
-68828000
Annuals > 1 > cash Flow > cash From Financing
32586000
Annuals > 1 > cash Flow > net Change In Cash
-98832000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-0.4501763996441027
Annuals > 1 > ratios > PB
-27.272735303200452
Annuals > 1 > ratios > ROE
61.8515959054982
Annuals > 1 > ratios > ROA
-23.408115728821873
Annuals > 1 > ratios > FCF
-33768000
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-1.245086833081376
Annuals > 1 > health Score
31
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
-
Annuals > 2 > income Statement > gross Profit
-
Annuals > 2 > income Statement > operating Expenses
19764000
Annuals > 2 > income Statement > operating Income
-19764000
Annuals > 2 > income Statement > interest Expense
-
Annuals > 2 > income Statement > pretax Income
-17929000
Annuals > 2 > income Statement > net Income
-17929000
Annuals > 2 > income Statement > eps
-
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
-
Annuals > 2 > income Statement > income Tax Expense
-
Annuals > 2 > income Statement > EBITDA
-19319000
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
1835000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
128597000
Annuals > 2 > balance Sheet > short Term Investments
0
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
132481000
Annuals > 2 > balance Sheet > property Plant Equipment
4865000
Annuals > 2 > balance Sheet > total Assets
138322000
Annuals > 2 > balance Sheet > payables
490000
Annuals > 2 > balance Sheet > short Term Debt
854000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
157552000
Annuals > 2 > balance Sheet > equity
-19230000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-17929000
Annuals > 2 > cash Flow > depreciation
445000
Annuals > 2 > cash Flow > change In Working Capital
-1139000
Annuals > 2 > cash Flow > cash From Operations
-18125000
Annuals > 2 > cash Flow > capital Expenditures
2307000
Annuals > 2 > cash Flow > cash From Investing
-2307000
Annuals > 2 > cash Flow > cash From Financing
119984000
Annuals > 2 > cash Flow > net Change In Cash
99552000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-
Annuals > 2 > ratios > PB
-
Annuals > 2 > ratios > ROE
93.23452938117525
Annuals > 2 > ratios > ROA
-12.961784820925088
Annuals > 2 > ratios > FCF
-20432000
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
41
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
15350000
Annuals > 3 > income Statement > cost Of Revenue
19487000
Annuals > 3 > income Statement > gross Profit
-4137000
Annuals > 3 > income Statement > operating Expenses
56418000
Annuals > 3 > income Statement > operating Income
-60555000
Annuals > 3 > income Statement > interest Expense
77000
Annuals > 3 > income Statement > pretax Income
-61027000
Annuals > 3 > income Statement > net Income
-59194000
Annuals > 3 > income Statement > eps
-1.0957548984699619
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
54021205
Annuals > 3 > income Statement > income Tax Expense
-1833000
Annuals > 3 > income Statement > EBITDA
-52826000
Annuals > 3 > income Statement > operating Margin
-394.49511400651465
Annuals > 3 > income Statement > total Other Income Expense Net
-472000
Annuals > 3 > income Statement > currency_symbol
-
Annuals > 3 > balance Sheet > cash
80485000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
3793000
Annuals > 3 > balance Sheet > inventories
4094000
Annuals > 3 > balance Sheet > total Current Assets
91731000
Annuals > 3 > balance Sheet > property Plant Equipment
52283000
Annuals > 3 > balance Sheet > total Assets
161338000
Annuals > 3 > balance Sheet > payables
3630000
Annuals > 3 > balance Sheet > short Term Debt
313000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
57908000
Annuals > 3 > balance Sheet > equity
103430000
Annuals > 3 > balance Sheet > currency_symbol
-
Annuals > 3 > cash Flow > net Income
-59194000
Annuals > 3 > cash Flow > depreciation
8124000
Annuals > 3 > cash Flow > change In Working Capital
-4586000
Annuals > 3 > cash Flow > cash From Operations
-45195000
Annuals > 3 > cash Flow > capital Expenditures
27720000
Annuals > 3 > cash Flow > cash From Investing
-34942000
Annuals > 3 > cash Flow > cash From Financing
72300000
Annuals > 3 > cash Flow > net Change In Cash
-7837000
Annuals > 3 > cash Flow > currency_symbol
-
Annuals > 3 > ratios > PE
-1.0957548984699619
Annuals > 3 > ratios > PB
10.367600495504206
Annuals > 3 > ratios > ROE
-57.23097747268684
Annuals > 3 > ratios > ROA
-36.68943460313132
Annuals > 3 > ratios > FCF
-72915000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-4.750162866449512
Annuals > 3 > health Score
22
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
13.730738129676661
Profitability > metrics > ROA
-4.007272654751656
Profitability > metrics > Net Margin
-12.921757770632368
Profitability > final Score
27
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
-4.982472912683238
Risk > final Score
10
Risk > verdict
High
Liquidity > metrics > Current Ratio
93.60703173615433
Liquidity > metrics > Quick Ratio
93.60703173615433
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
50
Prev Valuations > 1
20
Prev Valuations > 2
20
Prev Profitabilities > 0
17
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
0
Prev Risks > 1
-91
Prev Risks > 2
-59
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T23:14:21.940Z
Earnings History > 0 > period
2024-09-30
Earnings History > 0 > report Date
2024-11-14
Earnings History > 0 > date
2024-09-30
Earnings History > 0 > before After Market
BeforeMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.04
Earnings History > 0 > eps Estimate
-0.08
Earnings History > 0 > eps Difference
0.04
Earnings History > 0 > surprise Percent
50
Earnings History > 1 > period
2024-03-31
Earnings History > 1 > report Date
2024-05-13
Earnings History > 1 > date
2024-03-31
Earnings History > 1 > before After Market
BeforeMarket
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.14
Earnings History > 1 > eps Estimate
-0.12
Earnings History > 1 > eps Difference
-0.02
Earnings History > 1 > surprise Percent
-16.6667
Earnings History > 2 > period
2023-12-31
Earnings History > 2 > report Date
2024-02-13
Earnings History > 2 > date
2023-12-31
Earnings History > 2 > before After Market
BeforeMarket
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.19
Earnings History > 2 > eps Estimate
-0.18
Earnings History > 2 > eps Difference
-0.01
Earnings History > 2 > surprise Percent
-5.5556
Earnings History > 3 > period
2023-09-30
Earnings History > 3 > report Date
2023-11-13
Earnings History > 3 > date
2023-09-30
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.27
Earnings History > 3 > eps Estimate
-0.18
Earnings History > 3 > eps Difference
-0.09
Earnings History > 3 > surprise Percent
-50
Earnings History > 4 > period
2023-03-31
Earnings History > 4 > report Date
2023-05-08
Earnings History > 4 > date
2023-03-31
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
-0.2
Earnings History > 4 > eps Estimate
-0.21
Earnings History > 4 > eps Difference
0.01
Earnings History > 4 > surprise Percent
4.7619
Earnings History > 5 > period
2022-12-31
Earnings History > 5 > report Date
2023-02-07
Earnings History > 5 > date
2022-12-31
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
-
Earnings History > 5 > eps Actual
-0.19
Earnings History > 5 > eps Estimate
-0.25
Earnings History > 5 > eps Difference
0.06
Earnings History > 5 > surprise Percent
24
Earnings History > 6 > period
2022-09-30
Earnings History > 6 > report Date
2022-11-14
Earnings History > 6 > date
2022-09-30
Earnings History > 6 > before After Market
BeforeMarket
Earnings History > 6 > currency
-
Earnings History > 6 > eps Actual
-0.28
Earnings History > 6 > eps Estimate
-0.23
Earnings History > 6 > eps Difference
-0.05
Earnings History > 6 > surprise Percent
-21.7391
Earnings History > 7 > period
2022-03-31
Earnings History > 7 > report Date
2022-05-02
Earnings History > 7 > date
2022-03-31
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
-
Earnings History > 7 > eps Actual
-0.22
Earnings History > 7 > eps Estimate
-0.23
Earnings History > 7 > eps Difference
0.01
Earnings History > 7 > surprise Percent
4.3478
Earnings History > 8 > period
2021-12-31
Earnings History > 8 > report Date
2022-01-31
Earnings History > 8 > date
2021-12-31
Earnings History > 8 > before After Market
BeforeMarket
Earnings History > 8 > currency
-
Earnings History > 8 > eps Actual
-0.23
Earnings History > 8 > eps Estimate
-0.23
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
0
Earnings History > 9 > period
2021-09-30
Earnings History > 9 > report Date
2021-11-01
Earnings History > 9 > date
2021-09-30
Earnings History > 9 > before After Market
BeforeMarket
Earnings History > 9 > currency
-
Earnings History > 9 > eps Actual
-0.21
Earnings History > 9 > eps Estimate
-0.19
Earnings History > 9 > eps Difference
-0.02
Earnings History > 9 > surprise Percent
-10.5263
Earnings History > 10 > period
2021-03-31
Earnings History > 10 > report Date
2021-05-03
Earnings History > 10 > date
2021-03-31
Earnings History > 10 > before After Market
BeforeMarket
Earnings History > 10 > currency
-
Earnings History > 10 > eps Actual
-0.15
Earnings History > 10 > eps Estimate
-0.21
Earnings History > 10 > eps Difference
0.06
Earnings History > 10 > surprise Percent
28.5714
Earnings History > 11 > period
2020-12-31
Earnings History > 11 > report Date
2021-02-01
Earnings History > 11 > date
2020-12-31
Earnings History > 11 > before After Market
BeforeMarket
Earnings History > 11 > currency
-
Earnings History > 11 > eps Actual
-0.22
Earnings History > 11 > eps Estimate
-0.2
Earnings History > 11 > eps Difference
-0.02
Earnings History > 11 > surprise Percent
-10
Earnings History > 12 > period
2020-09-30
Earnings History > 12 > report Date
2020-10-30
Earnings History > 12 > date
2020-09-30
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
-
Earnings History > 12 > eps Actual
-0.23
Earnings History > 12 > eps Estimate
-0.2
Earnings History > 12 > eps Difference
-0.03
Earnings History > 12 > surprise Percent
-15
Earnings History > 13 > period
2020-03-31
Earnings History > 13 > report Date
2020-05-01
Earnings History > 13 > date
2020-03-31
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
-
Earnings History > 13 > eps Actual
-0.21
Earnings History > 13 > eps Estimate
-0.21
Earnings History > 13 > eps Difference
0
Earnings History > 13 > surprise Percent
0
Earnings History > 14 > period
2019-12-31
Earnings History > 14 > report Date
2020-01-31
Earnings History > 14 > date
2019-12-31
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
-
Earnings History > 14 > eps Actual
-0.3
Earnings History > 14 > eps Estimate
-0.22
Earnings History > 14 > eps Difference
-0.08
Earnings History > 14 > surprise Percent
-36.3636
Earnings History > 15 > period
2019-06-30
Earnings History > 15 > report Date
2019-09-13
Earnings History > 15 > date
2019-06-30
Earnings History > 15 > before After Market
AfterMarket
Earnings History > 15 > currency
-
Earnings History > 15 > eps Actual
-0.18
Earnings History > 15 > eps Estimate
-0.24
Earnings History > 15 > eps Difference
0.06
Earnings History > 15 > surprise Percent
25
Earnings History > 16 > period
2019-03-31
Earnings History > 16 > report Date
2019-05-10
Earnings History > 16 > date
2019-03-31
Earnings History > 16 > before After Market
AfterMarket
Earnings History > 16 > currency
-
Earnings History > 16 > eps Actual
-0.31
Earnings History > 16 > eps Estimate
-0.22
Earnings History > 16 > eps Difference
-0.09
Earnings History > 16 > surprise Percent
-40.9091
Earnings History > 17 > period
2018-12-31
Earnings History > 17 > report Date
2019-02-04
Earnings History > 17 > date
2018-12-31
Earnings History > 17 > before After Market
AfterMarket
Earnings History > 17 > currency
-
Earnings History > 17 > eps Actual
-0.24
Earnings History > 17 > eps Estimate
-0.23
Earnings History > 17 > eps Difference
-0.01
Earnings History > 17 > surprise Percent
-4.3478
Earnings History > 18 > period
2018-09-30
Earnings History > 18 > report Date
2018-11-05
Earnings History > 18 > date
2018-09-30
Earnings History > 18 > before After Market
BeforeMarket
Earnings History > 18 > currency
-
Earnings History > 18 > eps Actual
-0.33
Earnings History > 18 > eps Estimate
-0.23
Earnings History > 18 > eps Difference
-0.1
Earnings History > 18 > surprise Percent
-43.4783
Earnings History > 19 > period
2018-03-31
Earnings History > 19 > report Date
2018-05-15
Earnings History > 19 > date
2018-03-31
Earnings History > 19 > before After Market
BeforeMarket
Earnings History > 19 > currency
-
Earnings History > 19 > eps Actual
-0.19
Earnings History > 19 > eps Estimate
-0.23
Earnings History > 19 > eps Difference
0.04
Earnings History > 19 > surprise Percent
17.3913
Earnings History > 20 > period
2017-12-31
Earnings History > 20 > report Date
2018-02-14
Earnings History > 20 > date
2017-12-31
Earnings History > 20 > before After Market
AfterMarket
Earnings History > 20 > currency
-
Earnings History > 20 > eps Actual
-0.2
Earnings History > 20 > eps Estimate
-0.18
Earnings History > 20 > eps Difference
-0.02
Earnings History > 20 > surprise Percent
-11.1111
Earnings History > 21 > period
2017-09-30
Earnings History > 21 > report Date
2017-11-14
Earnings History > 21 > date
2017-09-30
Earnings History > 21 > before After Market
AfterMarket
Earnings History > 21 > currency
-
Earnings History > 21 > eps Actual
-0.24
Earnings History > 21 > eps Estimate
-0.18
Earnings History > 21 > eps Difference
-0.06
Earnings History > 21 > surprise Percent
-33.3333
Earnings History > 22 > period
2016-03-31
Earnings History > 22 > report Date
2016-06-29
Earnings History > 22 > date
2016-03-31
Earnings History > 22 > before After Market
AfterMarket
Earnings History > 22 > currency
-
Earnings History > 22 > eps Actual
-0.06
Earnings History > 22 > eps Estimate
-0.08
Earnings History > 22 > eps Difference
0.02
Earnings History > 22 > surprise Percent
25
Earnings History > 23 > period
2015-12-31
Earnings History > 23 > report Date
2016-02-16
Earnings History > 23 > date
2015-12-31
Earnings History > 23 > before After Market
AfterMarket
Earnings History > 23 > currency
-
Earnings History > 23 > eps Actual
-0.08
Earnings History > 23 > eps Estimate
-0.08
Earnings History > 23 > eps Difference
0
Earnings History > 23 > surprise Percent
0
Aktis Oncology, Inc. operates as a clinical-stage oncology company that engages in the development of targeted radiopharmaceutical therapies for cancer treatment. The company offers a miniprotein radioconjugate platform to discover and develop radiopharmaceutical therapies that deliver the tumor-killing properties of radioisotopes. It offers Nectin-4, a miniprotein radioconjugate for the treatment of locally advanced or metastatic urothelial cancer. Its products include AKY-1189 to deliver a radioisotope to Nectin-4 expressing tumors for the treatment of metastatic urothelial cancer, breast cancer, NSCLC, colorectal cancer and cervical cancer; and AKY-2519 to deliver radioisotope to B7-H3 CD276 expressing tumors targeting prostate, lung and other solid tumors. The company was formerly known as HotKnot Therapeutics, Inc. and changed its name to Aktis Oncology, Inc. in April 2020. Aktis Oncology, Inc. was incorporated in 2020 and is based in Boston, Massachusetts.
Stock Price
$0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AAssessing Aktis Oncology (AKTS) Valuation After IPO, NASDAQ Inclusion And Heavy Insider And Institutional Buying Yahoo Finance
Read more →Showing 2 of 10
(Last Updated 2024-12-31)
Health Score
Return on Equity (ROE)
-
Medium
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
* Institutions hold a combined 0.00% of the total shares of Aktis Oncology, Inc. Common stock
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2024-09-30
EPS Actual
-0.04
EPS Estimate
-0.08
EPS Difference
0.04
Surprise Percent
50%
(Last Updated 2024-12-31)
(Last Updated 2024-12-31)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2024-12-31)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2024-12-31)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.